Discovery of VEGFR2 inhibitors by integrating naïve Bayesian classification, molecular docking and drug screening approaches

The high morbidity and mortality of cancer make it one of the leading causes of global death, thus it is an urgent need to develop effective drugs for cancer therapy. Vascular endothelial growth factor receptor-2 (VEGFR2) acts as a central modulator of angiogenesis, and is therefore an important pha...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, De, Pang, Xiaocong, Lian, Wenwen, Xu, Lvjie, Wang, Jinhua, Jia, Hao, Zhang, Baoyue, Liu, Ai-Lin, Du, Guan-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2018
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9078101/
https://www.ncbi.nlm.nih.gov/pubmed/35542432
http://dx.doi.org/10.1039/c7ra12259d

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9078101/
https://www.ncbi.nlm.nih.gov/pubmed/35542432
http://dx.doi.org/10.1039/c7ra12259d

Ejemplares similares